FTC Pushes For Separate Trial In AndroGel Antitrust Suit
By Matt Bernardini ( August 21, 2018, 6:05 PM EDT) -- The Federal Trade Commission has said it wants a separate trial from private buyers and retailers in a decade-old antitrust suit over whether drugmakers conspired to delay generic versions of testosterone drug AndroGel through patent settlements, telling a Georgia federal judge that a combined trial would pull focus from its enforcement action....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.